"Stem Cells, Pluripotency and Nuclear Reprogramming", Dr. Rudolf Jaenisch, MIT

Every year, the Princess Takamatsu Cancer Research Fund invites a distinguished researcher who contributed to the development of cancer research, to present an international lecture. The lecture is given in Tokyo and two other cities, and this year, Okinawa (OIST) was chosen as one of those other locations.

This year’s lecturer is Dr. Rudolf Jaenisch, a Professor of Biology at MIT’s Whitehead Institute for Biomedical Research. Dr. Jaenisch is a pioneer in epigenetic science, who discovered that DNA modifications, such as methylation, play an important role in development and differentiation. In 1992, he created a DNA methyltransferase knockout mouse and showed that this mutation led to embryonic death. Last year, he reported that deletion of DNMT3A induced lung cancer in mice. Dr. Jaenisch is also a leader in the field of iPS cell science. He identified transcription factors for pluripotency, reprogramming, and regeneration, and clarified their functions. In this lecture, Dr. Jaenisch will discuss current research and its potential applications and pitfalls with regard to individualized medicine.

• Date: Friday, November 30, 2012, 11:00 - 12:30
• Venue: OIST B250 Seminar Room
• Title: "Stem Cells, Pluripotency and Nuclear Reprogramming"
• Speaker: Dr. Rudolf Jaenisch
  Member, Whitehead Institute for Biomedical Research
  Professor, Department of Biology, Massachusetts Institute of Technology, MA, USA
• Language: English

Poster (PDF)